Lanier Biotherapeutics
Bogart, US · Founded 2021 · Delaware corporation
Lanier Biotherapeutics is a biotherapeutics company. The page provides no specific detail about its products, pipeline, or target market.
Founders & leadership
MA
Martin A. SimonettiNamed on SEC filing
KN
Kirby N. AltonNamed on SEC filing
CM
Christopher McLeodNamed on SEC filing
DW
Daniel WhiteNamed on SEC filing
LS
Lewis ScruggsNamed on SEC filing
Board
KA
Kirby Alton
MS
Martin Simonetti
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 1 round · 2021
▶$3.1MraisedNov 2022 · 47 investors · BiotechnologyRule 506(b)
▶$3.1MraisedNov 2022 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin A. SimonettiDirector
- Kirby N. AltonDirector
- Christopher McLeodDirector
- Daniel WhiteExecutive Officer, Director, Promoter
- Lewis ScruggsDirector
- Offering amount
- $4.9M
- Amount sold
- $3.1M
- Minimum investment
- $25K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Lanier Biotherapeutics do?
- Lanier Biotherapeutics is a biotherapeutics company. The page provides no specific detail about its products, pipeline, or target market.
- How much funding has Lanier Biotherapeutics raised?
- Lanier Biotherapeutics has disclosed $3.1M raised across 1 round.
- Where is Lanier Biotherapeutics headquartered?
- Lanier Biotherapeutics is headquartered in Bogart, US.